Showing results (1-10 of 18) with videos related to
Sort By:
Pageof 2
BMJ Open|August 5, 2016
Live cumulative network meta-analysis: protocol for second-line treatments in advanced non-small-cell lung cancer with wild-type or unknown status for epidermal growth factor receptorPerrine Créquit, Ludovic Trinquart, Philippe RavaudJournal of the National Cancer Institute|January 8, 2019
Use of Late-Life Expectancy for Assessing the Long-Term Benefit of Immune Checkpoint InhibitorsAlexandre Vivot, Perrine Créquit, Raphaël PorcherBMC Medicine|April 8, 2021
Reporting of harms in oncological clinical study reports submitted to the European Medicines Agency compared to trial registries and publications-a methodological reviewAsger S Paludan-Müller, Perrine Créquit, Isabelle BoutronJournal of Cancer Policy|July 2, 2022
Availability of results of academic randomized trials involving cooperative groups in oncology in France: A systematic search of clinical trial registriesPerrine Créquit, Alexandre Vivot, Jules Grégory, et al.La Revue Du Praticien|December 5, 2018
[Diagnostic and therapeutic strategy in lung cancer]Nathalie Rozensztajn, Perrine Créquit, Marie Wislez, et al.BMC Medicine|January 22, 2016
Wasted research when systematic reviews fail to provide a complete and up-to-date evidence synthesis: the example of lung cancerPerrine Créquit, Ludovic Trinquart, Amélie Yavchitz, et al.Journal of Clinical Epidemiology|December 12, 2018
Automatic screening using word embeddings achieved high sensitivity and workload reduction for updating living network meta-analysesIvan Lerner, Perrine Créquit, Philippe Ravaud, et al.Journal of Medical Internet Research|May 17, 2018
Mapping of Crowdsourcing in Health: Systematic ReviewPerrine Créquit, Ghizlène Mansouri, Mehdi Benchoufi, et al.JHEP Reports : Innovation in Hepatology|January 25, 2021
Published trials of TACE for HCC are often not registered and subject to outcome reporting biasJules Grégory, Perrine Créquit, Valérie Vilgrain, et al.European Radiology|May 2, 2020
Results of trials assessing transarterial chemoembolization for treating hepatocellular carcinoma are critically underreportedJules Grégory, Perrine Créquit, Valérie Vilgrain, et al.Pageof 2